Visiopharm of Hørsholm, Denmark, and Hamamatsu of Hamamatsu City, Japan, have announced a nonexclusive worldwide OEM agreement and reseller partnership for Visiopharm’s quantitative digital pathology (QDP) solutions. Under the agreement, Visiopharm will serve as an OEM for Hamamatsu’s NDP.Analyze software, a research tool for tissue image analysis that is fully compatible with Visiopharm’s suite of QDP solutions. Hamamatsu will market and sell the suite of QDP solutions, including CloudAnalysis, DeployedAnalysis, Stereology and Application Protocol Packages from Visiopharm’s new APPCenter. Hamamatsu, which is known for its NanoZoomer Digital Pathology (NDP) whole slide scanners, will expand its offering to include quantitative digital pathology.